205 related articles for article (PubMed ID: 12045893)
1. Increased severity of herpes simplex virus type 1-induced keratitis in Hox A5 transgenic mice.
Galle LE; Taus NS; Maggs DJ; Moore CP; Mitchell WJ
Curr Eye Res; 2001 Dec; 23(6):435-42. PubMed ID: 12045893
[TBL] [Abstract][Full Text] [Related]
2. Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1.
Bhattacharjee PS; Neumann DM; Foster TP; Bouhanik S; Clement C; Vinay D; Thompson HW; Hill JM
Exp Eye Res; 2008 Aug; 87(2):122-30. PubMed ID: 18572164
[TBL] [Abstract][Full Text] [Related]
3. Loss of ICP22 in HSV-1 Elicits Immune Infiltration and Maintains Stromal Keratitis Despite Reduced Primary and Latent Virus Infectivity.
Matundan HH; Jaggi U; Wang S; Ghiasi H
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3398-3406. PubMed ID: 31387116
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus pathogenesis in transgenic mice is altered by the homeodomain protein Hox 1.3.
Mitchell WJ; De Santo RJ; Zhang SD; Odenwald WF; Arnheiter H
J Virol; 1993 Aug; 67(8):4484-91. PubMed ID: 8392593
[TBL] [Abstract][Full Text] [Related]
5. Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea.
Polcicova K; Biswas PS; Banerjee K; Wisner TW; Rouse BT; Johnson DC
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11462-7. PubMed ID: 16055558
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.
Alekseev O; Donovan K; Azizkhan-Clifford J
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):706-15. PubMed ID: 24370835
[TBL] [Abstract][Full Text] [Related]
7. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions.
Gangappa S; Deshpande SP; Rouse BT
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):453-9. PubMed ID: 10670475
[TBL] [Abstract][Full Text] [Related]
8. Role of miR-155 in the pathogenesis of herpetic stromal keratitis.
Bhela S; Mulik S; Gimenez F; Reddy PB; Richardson RL; Varanasi SK; Jaggi U; Xu J; Lu PY; Rouse BT
Am J Pathol; 2015 Apr; 185(4):1073-84. PubMed ID: 25700796
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
10. Application of FGF-2 to modulate herpetic stromal keratitis.
Kim B; Lee S; Kaistha SD; Rouse BT
Curr Eye Res; 2006 Dec; 31(12):1021-8. PubMed ID: 17169840
[TBL] [Abstract][Full Text] [Related]
11. Cytokine expression in murine corneas during recurrent herpetic stromal keratitis.
Keadle TL; Usui N; Laycock KA; Kumano Y; Pepose JS; Stuart PM
Ocul Immunol Inflamm; 2001 Sep; 9(3):193-205. PubMed ID: 11815888
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice.
Komatsu K; Miyazaki D; Morohoshi K; Kuo CH; Kakimaru-Hasegawa A; Komatsu N; Namba S; Haino M; Matsushima K; Inoue Y
Curr Eye Res; 2008 Sep; 33(9):736-49. PubMed ID: 18798077
[TBL] [Abstract][Full Text] [Related]
13. A forward phenotypically driven unbiased genetic analysis of host genes that moderate herpes simplex virus virulence and stromal keratitis in mice.
Thompson RL; Williams RW; Kotb M; Sawtell NM
PLoS One; 2014; 9(3):e92342. PubMed ID: 24651695
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
15. IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis.
Keadle TL; Usui N; Laycock KA; Miller JK; Pepose JS; Stuart PM
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):96-102. PubMed ID: 10634607
[TBL] [Abstract][Full Text] [Related]
16. Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis.
Nguyen QD; Uy HS; Merchant A; Medina CA; Baltatzis S; Zhao T; Zhao ZS; Cantor H; Foster CS
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2505-9. PubMed ID: 11581190
[TBL] [Abstract][Full Text] [Related]
17. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis.
Banerjee K; Biswas PS; Kumaraguru U; Schoenberger SP; Rouse BT
J Immunol; 2004 Dec; 173(12):7575-83. PubMed ID: 15585885
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
Banerjee K; Biswas PS; Rouse BT
J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
Bauer D; Lu M; Wasmuth S; Li H; Yang Y; Roggendorf M; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):216-25. PubMed ID: 16047184
[TBL] [Abstract][Full Text] [Related]
20. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
